Dotted line represents the threshold used to consider a cell positive for Gnas in ( e
60 LIVER STIFFNESS MEASUREMENT TO DETECT SEVERE FIBROSIS AND CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS D INFECTION Dominique M Roulot 1,2 , Segolene Brichler 3 , Richard Layese 4 , Louis D'Alteroche 5 , Nathalie Ganne-Carri 6 , Christiane Stern 7 , Antonio Saviano 8 , Vincent Leroy 9 , Francoise Roudot-Thoraval 4 and Victor De Ledinghen 10 , (1)Unit D'hpatologie, Assistance Publique-Hpitaux De Paris, Hpital Avicenne, (2)Universit Sorbonne Paris Nord, (3)CHU Avicenne, (4)Aphp-Hopital Henri Mondor, (5)CHU Tours, (6)Hepatology Department, Avicenne Hospital, AP-HP, France, (7)Service dHpatologie, Hpital Beaujon, (8)University of Strasbourg, France, (9)Aphp, (10)Centre D'investigation De La Fibrose Hpatique, Bordeaux University Hospital, Pessac, France

As the off-label use of these agents continues to grow in type 1 diabetes, particularly in patients with obesity or insulin resistance, our results support the need for continued investigation and consideration of their role as adjunctive therapies, Garg said
Mounjaro's UK SmPC describes stepups in 2.5 mg increments after at least 4 weeks at a dose